2024
|
Invention
|
(s)-tianeptine and use in treating disorders and conditions associated with peroxisome proliferat... |
2023
|
Invention
|
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride.
The pres... |
|
Invention
|
Cyclobenzaprine treatment for post-acute sequelae of (sars)-cov-2 infection (pasc).
The present ... |
2022
|
Invention
|
Methods and compositions for the treatment of viral diseases.
The present disclosure relates to ... |
|
Invention
|
Cyclobenzaprine for treatment or prevention of sexual dysfunction associated with mental health c... |
|
Invention
|
Synthetic chimeric poxviruses.
The invention relates, in general, to synthetic chimeric poxvirus... |
|
Invention
|
Tianeptine oxalate and naloxone combination for the treatment of major depressive disorder. A com... |
|
Invention
|
Methods of inducing immune tolerance with modified anti-cd154 antibodies.
This disclosure relate... |
|
Invention
|
Methods of inducing immune tolerance with modified anti-cd154 antibodies. This disclosure relates... |
2021
|
Invention
|
Cyclobenzaprine treatment for fibromyalgia.
Methods for treating fibromyalgia and one or more of... |
|
Invention
|
Cyclobenzaprine treatment for alcohol use disorder.
The present disclosure provides a method for... |
|
Invention
|
Skin-based testing for detection of cell-mediated immune responses to sars-cov-2. The present dis... |
|
Invention
|
Skin-based testing for detection of cell-mediated immune responses to sars-cov-2.
The present di... |
|
Invention
|
Cyclobenzaprine treatment for sexual dysfunction.
The present disclosure provides a pharmaceutic... |
|
Invention
|
Recombinant poxvirus based vaccine against sars-cov-2 virus. The invention relates in various asp... |
|
Invention
|
Recombinant poxvirus based vaccine against sars-cov-2 virus.
The invention relates in various as... |
2020
|
Invention
|
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride. The prese... |
|
Invention
|
Modified tff2 polypeptides.
Described herein are modified TFF2 polypeptides, compositions compri... |
|
Invention
|
Modified tff2 polypeptides. Described herein are modified TFF2 polypeptides, compositions compris... |
|
Invention
|
Anti-cd154 antibodies and uses thereof.
This disclosure relates to anti-human CD154 antibodies w... |
|
Invention
|
Anti-cd154 antibodies and uses thereof. This disclosure relates to anti-human CD154 antibodies wi... |
2019
|
Invention
|
Tianeptine oxalate salts and polymorphs. Disclosed herein is an oxalate salt/co-crystal (tianepti... |
|
Invention
|
Methods of treating acute stress disorder and posttraumatic stress disorder.
This invention rela... |
|
Invention
|
Methods and compositions for treating fatigue associated with disordered sleep using very low dos... |
|
Invention
|
Eutectic formulations of cyclobenzaprine hydrochloride. The present invention relates to pharmace... |
|
Invention
|
Synthetic chimeric vaccinia virus.
The invention relates in various aspects to a synthetic chime... |
|
Invention
|
Labeled oxytocin and method of manufacture and use. 13N-oxytocin molecules after craniofacial or ... |
2018
|
Invention
|
Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodeg... |
2017
|
Invention
|
Synthetic chimeric poxviruses. The invention relates, in general, to synthetic chimeric poxviruse... |
|
Invention
|
Magnesium-containing oxytocin formulations and methods of use. Disclosed are methods and composit... |
2016
|
Invention
|
Pharmaceutical composition comprising sumatripan for treating migraine. The present application r... |
|
Invention
|
Magnesium-containing oxytocin formulations and methods of use. Disclosed are magnesium-containing... |
2013
|
Invention
|
Compositions and methods for transmucosal absorption.
The invention provides compositions and me... |
|
Invention
|
Methods for treatment of pain. The invention provides for methods and compositions for treatment ... |
2012
|
Invention
|
Methods and compositions for treating depression using cyclobenzaprine. The present invention rel... |
2010
|
Invention
|
Methods and compositions for treating symptoms associated with post-traumatic stress disorder usi... |